China Life Insurance Company

China Life Insurance Company Limited, commonly known as China Life, is a Beijing-headquartered insurance company incorporated in China. Its principal business is the provision of life insurance and annuity products, with related health and accident insurance offerings. The company is the listed insurance operating entity associated with China Life Insurance (Group) Company and is one of the largest life insurers in the Chinese market. The company traces its institutional history to the establishment of the People's Insurance Company of China in 1949 and operates within the broader development of China's state-linked insurance sector. Its business has historically combined protection products, savings-oriented policies, retirement and annuity products, and insurance services distributed through a large domestic network. China Life's positioning is consequently broader than that of a narrowly specialized protection insurer: it serves individual policyholders, families, employers, and institutional customers across multiple stages of financial and retirement planning. China Life became an internationally traded company through listings in Hong Kong and New York in 2003, followed by an A-share listing in Shanghai in 2007. Its American depositary shares were later withdrawn from the New York Stock Exchange. In 2022, the company announced that ADS trading would end on 1 September, citing limited trading activity and the administrative costs associated with maintaining the listing. The underlying H shares continued to trade in Hong Kong. The company's main product categories include traditional and participating life insurance, term and whole-life protection, endowment and savings-linked policies, annuities, health insurance, and accident insurance. Publicly associated product lines include Guoshou Fu and Xinyu Jinsheng, although product availability and policy specifications can vary by period, distribution channel, and regulatory approval. As with other major Chinese insurers, China Life also participates in long-term investment and asset-management activities connected with the deployment of insurance funds. China Life has maintained a substantial domestic presence and has been described as China's largest life insurer by market share as of April 2023. It has also appeared in major international corporate rankings, including the Fortune Global 500 and Forbes Global 2000. In 2023, China Life and New China Life Insurance each invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund, an initiative presented as a way to improve capital-use efficiency and expand long-term investment assets. The brand remains active, but its international footprint and corporate conduct have also attracted scrutiny. Reference material states that its Russian offices remained active in 2025 despite sanctions imposed on Russia after its full-scale invasion of Ukraine, and that the company advertised for employees there. This has prompted ethical questions about continued operations in that market. The company therefore combines the scale and institutional importance of a major Chinese financial brand with the regulatory, investment, geopolitical, and reputational issues associated with a large insurer operating across changing markets.

China Life Insurance Company's institutional background is connected to the formation of the People's Insurance Company of China in 1949, an important early milestone in the development of the modern Chinese insurance sector. Over subsequent decades, China's insurance industry evolved from a predominantly state-organized system into a large commercial market containing multiple national insurers, specialized financial institutions, and increasingly diverse distribution channels. China Life developed within this broader institutional transformation and became the listed insurance company associated with the China Life Insurance group. The company focuses primarily on life insurance and annuity business, while also offering health and accident coverage. Its portfolio reflects the multiple functions that life insurers perform in China: providing mortality and disability protection, accumulating policyholder savings, supporting retirement planning, and investing long-duration insurance funds. Its customer base includes individuals and families as well as institutional and employer-sponsored clients. The brand's scale has made it one of the most visible participants in China's insurance market and a major channel through which households purchase long-term financial-protection products. China Life expanded its access to international capital markets in 2003 through listings in Hong Kong and New York. It subsequently returned to the mainland equity market with a Shanghai A-share listing in 2007. The New York component was later discontinued. In 2022, the company announced the delisting of its American depositary shares, explaining that trading volumes were limited and that the costs of administering the ADS program were no longer justified. The H shares underlying the depositary receipts remained listed and traded in Hong Kong, preserving the company's principal overseas equity-market presence. The company has also used its balance sheet and investment platform to participate in long-term asset allocation. In 2023, China Life invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund, alongside an equal investment from New China Life Insurance. The stated objective was to improve the efficiency of capital utilization and expand long-term investment assets. This activity illustrates the importance of investment management to the economics of a large life insurer, whose liabilities and policy obligations generally extend over long periods. China Life has been included in prominent corporate rankings, including the Fortune Global 500 and Forbes Global 2000. Reference material describes it as China's largest life insurer by market share as of April 2023. Its business is principally associated with China, although the company has maintained overseas operations. In 2025, continued activity by its Russian offices and recruitment in Russia attracted ethical criticism because of the sanctions and geopolitical consequences associated with Russia's invasion of Ukraine. That issue demonstrates how the company's international operations can create reputational and compliance questions beyond its core insurance business. Today, China Life remains an active, publicly traded insurer with a broad product architecture spanning life protection, annuities, health insurance, accident insurance, savings-oriented products, and retirement-related coverage. Its history reflects the institutional development of Chinese insurance, the shift toward public capital markets, and the increasingly important relationship between insurance underwriting and long-term investment management.

1. 2023Investment in Honghu fund

   China Life invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund together with an equal investment by New China Life Insurance.

   Source
2. 2022American depositary shares scheduled for delisting

   China Life announced that its ADS program would end, citing low trading volume and the costs of maintaining the program, while its Hong Kong-listed H shares continued trading.

   Source
3. 2007Shanghai A-share listing

   The company expanded its public-market presence with a listing on the Shanghai Stock Exchange.

   Source
4. 2003Hong Kong and New York listings

   China Life became publicly traded in Hong Kong and New York through its H-share and American depositary share listings.

   Source
5. 1949Institutional predecessor established

   The company's institutional history is traced to the establishment of the People's Insurance Company of China, an important predecessor in the development of China's state-linked insurance sector.

   Source

A large, comprehensive Chinese life-insurance provider serving protection, savings, retirement, health, and accident-insurance needs.

• Life insuranceProtection insurance

  China Life's core business comprises life-insurance policies designed to provide benefits associated with death, survival, or other insured life events. The portfolio can include protection-oriented and savings-oriented structures, serving individuals and families seeking long-term financial security.

• AnnuitiesRetirement and income insurance

  Annuity products convert premiums or accumulated policy value into scheduled benefits or income streams. They support retirement planning and other long-duration financial needs and are an important product category for a large life insurer.

• Health insuranceHealth insurance

  China Life offers health-insurance coverage alongside its life business. These products address medical or health-related financial risks and broaden the company's relationship with policyholders beyond mortality protection.

• Accident insurancePersonal accident insurance

  Accident insurance provides coverage for specified accidental events and related consequences. Within China Life's broader portfolio, it complements life, health, and annuity products and can be sold through individual or institutional channels.

• Guoshou FuLife insurance product line

  Guoshou Fu is a product line publicly associated with China Life. It is included here as a branded offering rather than as a description of specific policy terms, which may differ by product version, market period, distribution channel, and regulatory approval.

• Xinyu JinshengLife and savings-oriented insurance product line

  Xinyu Jinsheng is a branded offering associated with China Life and generally presented within the company's long-term insurance and savings-oriented product portfolio. Detailed benefits and availability are not specified in the supplied reference material.

• 2023Investment in the Honghu Private Securities Investment FundStrategy

  China Life and New China Life Insurance sought to improve the use of insurance capital and increase long-term investment assets.

  What changed. China Life invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund, matching the investment made by New China Life Insurance.

  Aftermath. The investment expanded the company's disclosed participation in long-term financial-asset allocation, although the supplied material does not report subsequent returns or performance.

  Investment commitment. US$3.5 billion (2023)

  Source
• 2022Withdrawal of the American depositary share programStrategy

  The company stated that ADS trading volume was limited and that maintaining the program created administrative costs.

  What changed. China Life announced that its ADSs would be delisted, with 1 September 2022 intended to be the final trading day. The Hong Kong-listed H shares continued trading.

  Aftermath. The decision reduced China Life's publicly traded US-market presence while leaving its Hong Kong listing in place.

  Source

• 2025Continued Russian operations amid sanctionsControversy

  China Life's continued operation of Russian offices and reported recruitment activity in Russia, despite international sanctions following the invasion of Ukraine, generated ethical scrutiny. The issue concerns the reputational and geopolitical implications of maintaining commercial activity in that market; the supplied material does not establish a legal finding of wrongdoing by the company.

  Source

• 2023China Life invests in Honghu Private Securities Investment Fund

  China Life invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund. New China Life Insurance invested the same amount. The fund was intended to improve capital-use efficiency and increase long-term investment assets.

  Other
  Source
• 2022China Life announces withdrawal of American depositary shares

  China Life announced that its American depositary shares would be delisted, with 1 September 2022 intended as the final trading day. The company attributed the decision to limited ADS trading volume and the administrative costs of maintaining the listing. Its underlying H shares continued trading in Hong Kong.

  M&AOther
  Source

1. China Life Insurance Company
2. China Life Insurance official website